$1.740
-0.067 (-3.87%)At close
- High
- 1.820
- Open
- 1.810
- VWAP
- 1.73
- Vol
- 285.52K
- Mkt Cap
- 49.43M
- Low
- 1.620
- Amount
- 493.00K
- EV/EBITDA, TTM
- 0.00
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
Valuation Metrics
Events Timeline
News
8.511-20GlobenewswireXOMA Royalty Completes Acquisition of LAVA Therapeutics N.V.
8.511-13NewsfilterLAVA Reports Surpassing Minimum Requirement in Tender Offer and Plans to Withdraw from Nasdaq
7.010-20PRnewswireShareholder Alert: The Ademi Firm investigates whether LAVA Therapeutics N.V. is obtaining a Fair Price for its Public Shareholders in the Amendment to the Purchase Agreement
8.510-17GlobenewswireXOMA Royalty and LAVA Therapeutics Reveal Changes to Purchase Agreement
- 8.510-02Newsfilter
XOMA Royalty Prolongs Tender Offer to Purchase LAVA Therapeutics N.V.
LVTX FAQ — answered by Alphio AI
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer. It operates in the Healthcare sector.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.